Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test
Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.
Epic Sciences Raises $43M in Series F Round
Epic will use the funds to further develop its multi-analyte DefineMBC liquid biopsy and expand into other business areas.
Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research
Epic will access the center's liquid biopsy samples and expand its platform to in-depth characterization of cell-free fractions and circulating tumor cells.
Epic Sciences Receives CE Mark for Liquid Biopsy Test Collection Kit
The kit allows stable preservation and transport of blood samples for testing using the company's in-house clinical and research assays.
In Brief This Week: Loop Medical, Precision Therapeutics, Epic Sciences, and More
Loop Medical said this week that it has received a second grant from the Bill & Melinda Gates Foundation to support pre-production and clinical trials required for the global registration of its medical blood collection device.